{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:11:18Z","timestamp":1790892678214,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Although the anticancer role of curcumin has been extensively addressed in preclinical research, only a few studies were carried out in humans, with conflicting results. The aim of this systematic review is to collate together the results of the therapeutic effect of curcumin in cancer patients. A literature search was carried out in Pubmed, Scopus, and the Cochrane Central Register of Controlled Trials up to 29 January 2023. Only randomized controlled trials (RCTs) designed to evaluate the effects of curcumin on cancer progression, patient survival, or surgical\/histological response were included. Seven out of 114 articles, published between 2016 and 2022, were analyzed. They evaluated patients with locally advanced and\/or metastatic prostate, colorectal, and breast cancers, as well as multiple myeloma and oral leucoplakia. Curcumin was given as an add-on therapy in five studies. Cancer response was the most investigated primary endpoint and curcumin issued some positive results. On the contrary, curcumin was ineffective in improving overall or progression-free survival. The curcumin safety profile was favorable. In conclusion, available clinical evidence is not strong enough to support the therapeutic use of curcumin in cancer. New RCTs exploring the effects of different curcumin formulations in early-stage cancers would be welcome.<\/jats:p>","DOI":"10.3390\/pharmaceutics15041275","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T03:20:39Z","timestamp":1681874439000},"page":"1275","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Exploring the Contribution of Curcumin to Cancer Therapy: A Systematic Review of Randomized Controlled Trials"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4346-1494","authenticated-orcid":false,"given":"Chiara","family":"de Waure","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia, Piazza L. Severi 1, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Bertola","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia, Piazza L. Severi 1, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Baccarini","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia, Piazza L. Severi 1, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3551-7486","authenticated-orcid":false,"given":"Manuela","family":"Chiavarini","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Perugia, Piazza L. Severi 1, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Mancuso","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo F. Vito 1, 00168 Rome, Italy"},{"name":"Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Universit\u00e0 Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The Essential Medicinal Chemistry of Curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2011.09.004","article-title":"Natural substances and Alzheimer\u2019s disease: From preclinical studies to evidence based medicine","volume":"1822","author":"Mancuso","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mhillaj, E., Tarozzi, A., Pruccoli, L., Cuomo, V., Trabace, L., and Mancuso, C. (2019). Curcumin and heme oxygenase: Neuroprotection and beyond. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102419"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","article-title":"Curcumin as \u201cCurecumin\u201d: From kitchen to clinic","volume":"75","author":"Goel","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"891339","DOI":"10.3389\/fnut.2022.891339","article-title":"Curcuminoids for metabolic syndrome: Meta-analysis evidences toward personalized prevention and treatment management","volume":"9","author":"Nurcahyanti","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Silvestro, S., Sindona, C., Bramanti, P., and Mazzon, E. (2021). A state of the art of antioxidant properties of curcuminoids in neurodegenerative diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063168"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"108729","DOI":"10.1016\/j.cbi.2019.108729","article-title":"Therapeutic effects of turmeric in several diseases: An overview","volume":"310","author":"Hay","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jtcme.2016.05.005","article-title":"Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives\u2014A review","volume":"7","author":"Amalraj","year":"2016","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/ptr.6324","article-title":"Curcuminoids: Implication for inflammation and oxidative stress in cardiovascular diseases","volume":"33","author":"Li","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Liu, S., Liu, J., He, L., Liu, L., Cheng, B., Zhou, F., Cao, D., and He, Y. (2022). A comprehensive review on the benefits and problems of curcumin with respect to human health. Molecules, 27.","DOI":"10.3390\/molecules27144400"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Scuto, M.C., Mancuso, C., Tomasello, B., Ontario, M.L., Cavallaro, A., Frasca, F., Maiolino, L., Trovato Salinaro, A., Calabrese, E.J., and Calabrese, V. (2019). Curcumin, hormesis and the nervous system. Nutrients, 11.","DOI":"10.3390\/nu11102417"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113438","DOI":"10.1016\/j.biopha.2022.113438","article-title":"An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy","volume":"153","author":"Zhu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jcph.806","article-title":"Randomized pharmacokinetic crossover study comparing 2 curcumin preparations in plasma and rectal tissue of healthy human volunteers","volume":"57","author":"Asher","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2891-13-11","article-title":"Comparative absorption of curcumin formulations","volume":"13","author":"Lowery","year":"2014","journal-title":"Nutr. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/0250-474X.44591","article-title":"A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin","volume":"70","author":"Antony","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/jn\/nxab087","article-title":"Pharmacokinetics of a single dose of turmeric curcuminoids depends on formulation: Results of a human crossover study","volume":"151","author":"Tenon","year":"2021","journal-title":"J. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-011-1673-1","article-title":"Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers","volume":"69","author":"Kanai","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.freeradbiomed.2005.09.008","article-title":"Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups","volume":"40","author":"Chen","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0891-5849(03)00325-3","article-title":"Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin","volume":"35","author":"Priyadarsini","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vr\u00e2nceanu, M., Galimberti, D., Banc, R., Drago\u015f, O., Cozma-Petru\u0163, A., Heghe\u015f, S.C., Vo\u015ftinaru, O., Cuciureanu, M., Stroia, C.M., and Miere, D. (2022). The anticancer potential of plant-derived nutraceuticals via the modulation of gene expression. Plants, 11.","DOI":"10.3390\/plants11192524"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Younes, M., Mardirossian, R., Rizk, L., Fazlian, T., Khairallah, J.P., Sleiman, C., Naim, H.Y., and Rizk, S. (2022). The synergistic effects of curcumin and chemotherapeutic drugs in inhibiting metastatic, invasive and proliferative pathways. Plants, 11.","DOI":"10.3390\/plants11162137"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.31557\/APJCP.2021.22.6.1671","article-title":"A systematic review and meta-analysis on the efficacy of curcumin\/turmeric for the prevention and amelioration of radiotherapy\/radiochemotherapy induced oral mucositis in head and neck cancer patients","volume":"22","author":"Dharman","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/jcrt.JCRT_95_20","article-title":"Turmeric in the management of oral submucous fibrosis: A systematic review and meta-analysis","volume":"17","author":"Rai","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.1188\/20.ONF.E225-E236","article-title":"Radiodermatitis in patients with cancer: Systematic review and meta-analysis","volume":"47","author":"Ginex","year":"2020","journal-title":"Oncol. Nurs. Forum."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/ptr.6326","article-title":"Effects of turmeric and curcumin on oral mucositis: A systematic review","volume":"33","author":"Borges","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.21037\/jgo-22-259","article-title":"A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer","volume":"13","author":"Gunther","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_29","first-page":"375","article-title":"Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial","volume":"13","author":"Santosa","year":"2022","journal-title":"Casp. J. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/cam4.3806","article-title":"Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer","volume":"10","author":"Eymard","year":"2021","journal-title":"Cancer Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153218","DOI":"10.1016\/j.phymed.2020.153218","article-title":"Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial","volume":"70","author":"Saghatelyan","year":"2020","journal-title":"Phytomedicine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jn\/nxz029","article-title":"Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa trial","volume":"149","author":"Howells","year":"2019","journal-title":"J. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/pros.23766","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation","volume":"79","author":"Choi","year":"2019","journal-title":"Prostate"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1158\/1940-6207.CAPR-15-0390","article-title":"A randomized double-blind placebo-controlled phase IIB trial of curcumin in oral leukoplakia","volume":"9","author":"Kuriakose","year":"2016","journal-title":"Cancer Prev. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13063-015-0641-1","article-title":"Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): Study protocol for a randomised control trial","volume":"16","author":"Irving","year":"2015","journal-title":"Trials"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbagen.2007.11.016","article-title":"Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells","volume":"1780","author":"Kunwar","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1055-9965.120.14.1","article-title":"Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences","volume":"14","author":"Garcea","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"le3","DOI":"10.1074\/jbc.L110.133520","article-title":"Curcumin and Alzheimer disease: This marriage is not to be performed","volume":"286","author":"Mancuso","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tips.2009.04.004","article-title":"Curcumin in clinical practice: Myth or reality?","volume":"30","author":"Mancuso","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_40","unstructured":"Katzung, B.G., and Vanderah, T.W. (2021). Basic & Clinical Pharmacology, McGraw Hill. [15th ed.]."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/4\/1275\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:18:40Z","timestamp":1760123920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/4\/1275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["pharmaceutics15041275"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15041275","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}